[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,310
  • Shares Outstanding, K 13,895
  • Annual Sales, $ 17,440 K
  • Annual Income, $ -21,170 K
  • EBIT $ -21 M
  • EBITDA $ -20 M
  • 60-Month Beta 6.25
  • Price/Sales 0.53
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.14
  • Most Recent Earnings $-0.52 on 05/20/26
  • Next Earnings Date 08/18/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.37
  • Number of Estimates 3
  • High Estimate $-0.33
  • Low Estimate $-0.40
  • Prior Year $-0.55
  • Growth Rate Est. (year over year) +32.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5450 +28.44%
on 05/21/26
0.8666 -19.22%
on 05/01/26
-0.0825 (-10.54%)
since 04/29/26
3-Month
0.5450 +28.44%
on 05/21/26
1.5400 -54.55%
on 04/15/26
-0.7000 (-50.00%)
since 02/27/26
52-Week
0.5450 +28.44%
on 05/21/26
7.9500 -91.19%
on 07/11/25
-1.5900 (-69.43%)
since 05/28/25

Most Recent Stories

More News
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

Year-over-year revenue increased 70%, reflecting contribution from Vivos’ acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May...

VVOS : 0.7000 (+4.48%)
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics

The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution...

CAST : 0.8290 (+0.69%)
NTHI : 4.64 (-3.13%)
ACXP : 1.9800 (-0.50%)
IGC : 0.2889 (-0.28%)
VTIX : 3.70 (+2.78%)
MDCX : 0.3790 (+15.09%)
YYGH : 0.1900 (-18.10%)
DVLT : 0.5000 (+0.58%)
VVOS : 0.7000 (+4.48%)
Vivos Therapeutics Reports Full Year 2025 Financial Results

Full Year 2025 revenue increased 16% Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, margins and cash flow Management to Host Conference...

VVOS : 0.7000 (+4.48%)
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment...

VVOS : 0.7000 (+4.48%)
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)

The show will air as sponsored programming nationwide at 10:30 PM PST on Fox Business Network

SDST : 2.28 (-4.60%)
VTIX : 3.70 (+2.78%)
MDCX : 0.3790 (+15.09%)
YYGH : 0.1900 (-18.10%)
VVOS : 0.7000 (+4.48%)
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

LITTLETON, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment...

VVOS : 0.7000 (+4.48%)
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)

The show also broadcasts across MENA and Latin America as sponsored programming.

TRN : 32.44 (+0.90%)
PETV : 0.7591 (-4.85%)
SNYR : 0.2690 (-3.31%)
ACXP : 1.9800 (-0.50%)
IGC : 0.2889 (-0.28%)
VTIX : 3.70 (+2.78%)
LTRN : 3.59 (+2.57%)
NRXP : 4.42 (-0.45%)
YYGH : 0.1900 (-18.10%)
DVLT : 0.5000 (+0.58%)
VVOS : 0.7000 (+4.48%)
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

Insurance Coverage on Vivos Appliances and Treatment Now Available to a Significant Number of Nevada Patients Previously Unable to Access Coverage Concurrently, Vivos Implements Cost Reduction Initiatives...

VVOS : 0.7000 (+4.48%)
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS),  a leading medical device and healthcare services company focused...

VVOS : 0.7000 (+4.48%)
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST

The Show Will Also Air Across Latin America and MENA 1230 pm local time.

VTIX : 3.70 (+2.78%)
MDCX : 0.3790 (+15.09%)
CITR : 6.59 (-2.95%)
VVOS : 0.7000 (+4.48%)

Business Summary

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

See More

Key Turning Points

3rd Resistance Point 0.7400
2nd Resistance Point 0.7200
1st Resistance Point 0.7100
Last Price 0.7000
1st Support Level 0.6800
2nd Support Level 0.6600
3rd Support Level 0.6500

See More

52-Week High 7.9500
Fibonacci 61.8% 5.1213
Fibonacci 50% 4.2475
Fibonacci 38.2% 3.3737
Last Price 0.7000
52-Week Low 0.5450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.